Company Filing History:
Years Active: 2001-2007
Title: Katherine L. Worledge: Innovator in Inflammatory Bowel Disease Treatment
Introduction
Katherine L. Worledge is a prominent inventor based in Madison, WI (US). She has made significant contributions to the field of medical research, particularly in the treatment of inflammatory bowel disease. With a total of 4 patents, her work has the potential to impact the lives of many suffering from this condition.
Latest Patents
Worledge's latest patents focus on the use of antibodies to cytokines in the prevention and treatment of inflammatory bowel disease. The methods described in her patents detail how specific avian polyclonal antibodies directed to proinflammatory cytokines, such as IL-6 and TNF, can have a beneficial effect in animal models. These models are predictive of human therapy for the treatment of colitis, including Crohn's disease. Her innovative approach offers new avenues for effective treatment options.
Career Highlights
Throughout her career, Katherine has worked with notable companies such as Promega Corporation and Ophidian Pharmaceuticals, Inc. Her experience in these organizations has allowed her to develop and refine her research, leading to her impactful patents.
Collaborations
Some of her notable coworkers include John A. Kink and Douglas C. Stafford. Their collaboration has contributed to the advancement of research in the field of inflammatory bowel disease.
Conclusion
Katherine L. Worledge is a dedicated inventor whose work in the treatment of inflammatory bowel disease showcases her commitment to medical innovation. Her patents and collaborations highlight her significant contributions to the field, paving the way for future advancements in treatment options.